硬性透气角膜接触镜矫治儿童弱视的临床观察  

Clinical effects of rigid gas-permeable contact lenses on amblyopia in children

作　　者：钱进[1] 徐玉红[1] 史建明[1] 熊国强[1] 祝鋆[1] 陈忆伟[1] 杨冠[2] 

机构地区：[1]上海市第二人民医院眼科,200011 [2]上海市第六人民医院眼科

出　　处：《临床眼科杂志》2011年第5期439-441,共3页Journal of Clinical Ophthalmology

摘　　要：目的探讨硬性透气角膜接触镜(RGPCL)对儿童弱视的矫治作用。方法在明确诊断为弱视并已配戴框架眼镜辅以遮盖等其他方法治疗1年以上无效者中选取两组对象,其弱视主要原因为屈光因素,41例(57只眼)作为RGPCL配戴组,其中男18例,女23例,平均年龄为(9.5±3.1);同期42例(60只眼)继续配戴框架眼镜作为对照组,其中男20例,女22例,平均年龄为(9.3±3.3)岁;两组戴镜后继续辅以遮盖等弱视综合治疗,历时三年,观察其戴镜前后的矫正视力,比较两组疗效。结果 3年后两组病例的矫正视力都有提高,RGP组有27只眼矫正视力达5.0,基本治愈率为47.36%,而框架眼镜组仅6只眼视力达5.0,治愈率为10%,两组有非常显著差异(P<0.01);RGPCL组有26只眼视力进步,视力平均提高4.58行,总有效率92.98%,而框架眼镜组有24只眼视力进步,视力平均提高1.96行,总有效率为50%,两组有显著差异(P<0.01)。结论 RGPCL对儿童弱视的治疗效果明显优于框架眼镜。Objective To evaluate the effectiveness of using Rigid Gas-permeable（RGP） contact lens in curing amblyopia in children.Methods 83 children who had been treated with amblyopiatrics for more than one year with no improvement were divided into two groups called RGP group eyeglass frame group.RGP group with 41 amblyopia children 18 eyes of male,23 eyes of female,average age（9.5±3.1）] wore RGP lenses while eyeglass frame group with 42 amblyopia children 20 eyes of male,22 eyes of female,average age（9.3±3.3）] continued to wear eyeglass frames.Amblyopia therapy was given to both group.The effects of the treatment methods of three years were then compared.Results After three years,the corrected vision in both groups had improved.RGP group improved with an effective rate of 47.36%（27 eyes with 5.0） while eyeglass frame group improved with an effective rate only of 10%（6 eyes with 5.0）.Results differed significantly between the two groups（P〈0.001）.The vision of 26 eyes in RGP group had progressed with 4.58 line average,92.98% total effective rate while the vision of 24 eyes in eyeglass frame group were 1.96 line average,50% total effective rate.Results differed significantly between the two groups（P〈0.01）.Conclusion Usine RGP provides a more effective way of treatment than wearing eyeglass frame.

关 键 词：硬性透气角膜接触镜 弱视 儿童 治疗 

分 类 号：R777.44[医药卫生—眼科]